Oxford-AstraZeneca vaccine granted emergency use approval in Sri Lanka

The National Medicines Regulatory Authority (NMRA)  has granted approval for the emergency use of the Oxford-AstraZeneca vaccine for Covoid-19 in Sri Lanka.

State Minister Dr. Channa Jayasumana said the vaccine is expected to reach Sri Lanka soon.

He said that this was the first time the NMRA has approved a COVID-19 vaccine.

The State Minister said that the NMRA has received applications seeking approval for other COVID-19 vaccines as well.

Unlike Pfizer’s jab – which has to be kept at an extremely cold temperature (-70C) – the Oxford vaccine can be stored in a normal fridge. This makes it much easier to distribute.

Sri Lanka is likely to receive the Oxford-AstraZeneca vaccine from India.

India’s drug regulator had given the green light to Covishield (the local name for the Oxford-AstraZeneca vaccine developed in the UK) and Covaxin, locally-made by pharma company Bharat Biotech.

India has already shipped tens of thousands of free doses of the Covid-19 vaccine to neighbouring countries in what is being widely described as “vaccine diplomacy”. (Colombo Gazette)


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.